Ageing is a universal process that impacts every person differently. While some individuals seem to age gracefully, retaining their youthful looks and energy well into old age, others face the rapid onset of wrinkles, health issues, and signs of ageing. The factors behind this disparity are complex, involving genetics, lifestyle choices, and environmental influences. However, ground-breaking research is now unlocking the potential to measure and even predict how fast someone is ageing, with the help of a tool called “CheekAge.”

For decades, scientists have understood that certain lifestyle factors can accelerate the ageing process. Stress, poor diet, lack of sleep, smoking, and excessive alcohol consumption all play a significant role in this process. These factors don’t just make you feel older, they leave identifiable marks on your DNA. This is where the science of epigenetics comes in, which focuses on how environmental factors can cause changes in how genes work without altering the genetic code itself.

Recent advances in epigenetics have led to the development of “epigenetic clocks,” tools that can measure DNA changes to assess how fast someone is ageing. These clocks have traditionally relied on blood samples, but a new, simpler, and less invasive tool called CheekAge has emerged, offering a painless way to measure ageing using cells from the inside of the cheek.

How DNA Tells the Story: At the heart of the ageing process are DNA changes called “epigenetic modifications.” These are chemical changes that affect how genes are expressed, and they are influenced by factors like stress, diet, and lifestyle. Over time, these modifications accumulate and serve as markers of biological ageing, which can be very different from the chronological age on your driver’s license.

Epigenetic clocks work by identifying specific changes in DNA that correspond to ageing. These clocks have proven highly accurate in predicting the biological age of an individual, which reflects their overall health and risk of age-related diseases. However, the traditional method of measuring epigenetic changes using blood samples can be uncomfortable, invasive, and inconvenient for regular monitoring.

To solve this problem, a team of researchers from the United States has developed CheekAge, an epigenetic clock that uses cells from the inside of the cheek. This approach offers several advantages, as it is painless, simple, and quick, making it an ideal tool for routine health monitoring.

What Makes CheekAge So Important?
CheekAge is a new frontier in the study of human ageing, and it could have significant implications for both individual health and public health policy. By measuring DNA changes in cheek cells, researchers can gain insight into a person’s biological age and how it compares to their chronological age. More importantly, CheekAge can predict mortality risk, essentially forecasting how long someone might live based on their biological ageing markers.

In a recent study published in Frontiers in Aging, the researchers behind CheekAge examined more than 200,000 DNA sites from cheek cells of participants. These sites were analysed for signs of ageing, and the results were striking. The study revealed that the CheekAge clock could accurately predict mortality risk, with every small increase in CheekAge corresponding to a 21% rise in the risk of death from any cause.

This finding is crucial because it shows that CheekAge doesn’t just measure how fast someone is ageing it can also help identify people at higher risk of death or age-related diseases. Armed with this information, doctors and researchers may soon be able to intervene earlier, offering treatments or lifestyle changes that could extend a person’s life and improve their quality of life.

The DNA Markers Behind Ageing: One of the most exciting aspects of the CheekAge research is the identification of specific DNA markers linked to ageing and mortality. These markers provide clues about the biological processes that drive ageing and the development of age-related diseases like cancer, heart disease, and metabolic syndrome.

For example, one gene identified in the study, PDZRN4, is thought to play a role in suppressing tumour growth. This gene could be crucial in understanding how cancer develops in older adults and could lead to new treatments that slow or prevent the onset of cancer.

Another gene, ALPK2, has been linked to heart health and has been studied in animal models of heart disease and cancer. Understanding how this gene functions in humans could pave the way for treatments that prevent heart disease, a leading cause of death among older adults.

These findings highlight the potential of CheekAge to not only predict when someone might die but also to identify which age-related diseases they are most at risk for. As scientists continue to explore these genetic markers, we may see new therapies that target the root causes of ageing, leading to longer, healthier lives.

A Future Where Ageing is Predictable and Preventable?
The development of CheekAge represents a major breakthrough in our understanding of the ageing process. For the first time, we have a non-invasive, reliable tool that can predict biological ageing and mortality risk. This opens the door to a future where doctors could use CheekAge to monitor patients health over time and recommend interventions to slow down the ageing process.

Imagine a world where, instead of reacting to the signs of ageing after they appear, we can proactively manage our health to delay or even prevent the onset of age-related diseases. With tools like CheekAge, this future may not be far off.

What Could This Mean for You?
As CheekAge and similar tools become more widely available, they could become a standard part of health check-ups. By providing a quick, easy way to measure biological age, CheekAge could help individuals understand how their lifestyle choices are affecting their health and longevity.

If your biological age is higher than your chronological age, it might be a wake-up call to make changes to your lifestyle. A balanced diet, regular exercise, stress management, and quitting harmful habits like smoking and excessive alcohol use could all help to slow down the ageing process.

For people who are already at risk of age-related diseases, CheekAge could be a valuable tool for early intervention. By catching signs of accelerated ageing early, doctors could recommend treatments or lifestyle adjustments that could reduce the risk of serious health problems like cancer, heart disease, and diabetes.

The introduction of CheekAge marks an exciting step forward in the science of ageing, but there is still much to learn. Researchers are already planning further studies to explore how CheekAge can be used to predict not just death, but also the onset of specific diseases. As we gather more data, we may see even more advanced tools for predicting and managing ageing in the future.

In the meantime, CheekAge offers a powerful reminder that our health is not just determined by the number of years we’ve lived, but by how well we’ve lived those years. By paying attention to the factors that influence our biological age, we can all take steps to ensure a longer, healthier future.

Ageing is inevitable, but how we age is something we can influence. Tools like CheekAge offer new insights into the ageing process, providing an opportunity to monitor and manage our health more effectively. By identifying the DNA markers linked to ageing, CheekAge gives us a glimpse into the future of personalised medicine, where we can predict and prevent age-related diseases before they occur. With continued research, this technology could transform the way we think about ageing, helping us all to live longer, healthier lives.